Podrobno

Ukrepi za zmanjšanje sive ekonomije v Republiki Sloveniji : primer davčnih blagajn
ID Glumac, Eva (Avtor), ID Aristovnik, Aleksander (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (1,58 MB)
MD5: DA85B08AD40C5698AA46FEDC5C41ACFA
PID: 20.500.12556/rul/07620c0a-95a6-499d-8a66-eebcf77931a8

Jezik:Slovenski jezik
Ključne besede:siva ekonomija, davki, davčne blaganje, Slovenija, diplomske naloge
Vrsta gradiva:Diplomsko delo/naloga
Tipologija:2.11 - Diplomsko delo
Organizacija:FU - Fakulteta za upravo
Kraj izida:Ljubljana
Založnik:[E. Glumac]
Leto izida:2015
Št. strani:X, 46 str.
PID:20.500.12556/RUL-89606 Povezava se odpre v novem oknu
UDK:331.526.8(497.4)(043.2)
COBISS.SI-ID:4550318 Povezava se odpre v novem oknu
Datum objave v RUL:29.03.2017
Število ogledov:2062
Število prenosov:192
Metapodatki:XML DC-XML DC-RDF
:
GLUMAC, Eva, 2015, Ukrepi za zmanjšanje sive ekonomije v Republiki Sloveniji : primer davčnih blagajn [na spletu]. Diplomsko delo. Ljubljana : E. Glumac. [Dostopano 26 marec 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=89606
Kopiraj citat
Objavi na:Bookmark and Share

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj